Search for: "Novo Nordisk A/S" Results 61 - 80 of 308
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Jun 2011, 8:15 am by Dan Hargrove
See these articles:4-19-11 Annals of Internal Medicine - Systematic Review of Harms and Benefits of Factor VIIa(function() { var scribd = document.createElement("script"); scribd.type = "text/javascript"; scribd.async = true; scribd.src = "http://www.scribd.com/javascripts/embed_code/inject.js"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(scribd, s); })();4-19-11 Annals of Internal Medicine - Off-Label Use of… [read post]
14 Jun 2011, 4:43 am by Dan Hargrove
  I'll also post the congressional testimony by Army officers (from a few years back) about the Army's use of NovoSeven. [read post]
24 Apr 2012, 1:00 am by Courtenay Brinckerhoff
Novo Nordisk A/S, reversing the Federal Circuit decision and finding that 21 USC § 355(j)(5)(C)(ii)(I) provides a mechanism for a generic drug manufacturer to challenge the accuracy of a use code... [read post]
18 Apr 2012, 2:02 am by Marie Louise
Highlights this week included: Prandin (Repaglinide) - US: Supreme Court sides with generic pharmaceutical companies in dispute over Orange Book "use codes": Caraco v Novo Nordisk (Orange Book Blog) (FDA Law Blog) (Patently-O) [...] [read post]
17 Apr 2012, 8:28 pm by Aaron Barkoff
Novo Nordisk, 566 U.S. ___ (2012) In a unanimous opinion today, the Supreme Court held that an ANDA applicant may employ the counterclaim provision of 21 U.S.C. [read post]
18 Jul 2023, 11:45 am by Tom Lamb
"Novo Nordisk is aware of the signal and the request by EMA and will deliver a thorough assessment of all relevant data to elucidate this topic," Lars Otto Andersen-Lange, media relations director at Novo Nordisk, told Reuters.... [read post]
13 Sep 2023, 9:56 am by Katherine Kiziah
Now, however, Ozempic is in the national spotlight for a different reason: The drug’s manufacturer, Novo Nordisk, is facing lawsuits alleging that Ozempic causes gastroparesis, which is also referred to as “stomach paralysis. [read post]
13 Sep 2023, 9:56 am by Katherine Kiziah
Now, however, Ozempic is in the national spotlight for a different reason: The drug’s manufacturer, Novo Nordisk, is facing lawsuits alleging that Ozempic causes gastroparesis, which is also referred to as “stomach paralysis. [read post]
13 Sep 2023, 9:56 am by Katherine Kiziah
Now, however, Ozempic is in the national spotlight for a different reason: The drug’s manufacturer, Novo Nordisk, is facing lawsuits alleging that Ozempic causes gastroparesis, which is also referred to as “stomach paralysis. [read post]
29 Apr 2012, 9:35 pm by Patent Docs
Novo Nordisk and the Federal Circuit's decisions in AstraZeneca v. [read post]
25 Jun 2011, 3:43 pm by Dr Mark Summerfield
This decision in relation to an extension request by Novo Nordisk Health Care AG, by Hearing Officer Dr Steven Barker, is an example of an approach that failed to show that these basic requirements were satisfied. [read post]
24 Nov 2010, 6:14 pm by Barry Eagar
Case: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) [2010] 1251HeadnoteCSL failed "promptly" to consider whether or not amendments to its Australian patent should be made in response to amendments recommended in respect of corresponding foreign patent applications. [read post]
7 Nov 2019, 8:10 pm by Patent Docs
Notable advances include Takeda (up 142% based in part on its Shire acquisition, and jumping in the rankings from 23rd to 17th Q4 2018 – Q1 2019), with several other companies showing robust growth (including Celgene Corp., 37%; Novo Nordisk AS, 17%; Novartis AG, 14%; and Merck KGa, 13%; Hoffmann-La Roche, 12.7%). [read post]
5 Dec 2011, 10:38 am by Jaclyn Belczyk
Novo Nordisk A/S [transcript, PDF; JURIST report], the court heard arguments on drug patents. [read post]
10 Feb 2024, 5:36 am by Moll Law Group
However defendant Eli Lilly filed an objection to being part of the MDL with Novo Nordisk, since it is named in only a small number of lawsuits. [read post]
13 Jun 2011, 4:05 am by Dan Hargrove
As part of the settlement, Novo Nordisk has entered into a five-year Corporate Integrity Agreement and will have to beef up its compliance procedures, according to a statement from the drugmaker. [read post]
15 Jun 2011, 5:48 am by Dan Hargrove
  The Army needs to take a long, hard look at the ties between pharma companies (e.g., Novo Nordisk) and the military. [read post]